COVID-19: Disease, Management, Treatment, and Social Impact

Overview

Journal Sci Total Environ

Date 2020 Apr 29

PMID 32344226

Citations 161

Authors

Imran Ali

Omar M L Alharbi

Affiliations

Soon will be listed here.

Abstract

COVID-19 was originated from Wuhan city of Hubei Province in China in December 2019. Since then it has spread in more than 210 countries and territories. It is a viral disease due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. The patients show flu-like symptoms with a dry cough, sore throat, high fever, and breathing problems. The disease due to SARS-CoV-2 was named as COVID-19. About 2.2 million people have been infected with more than 0.15 million deaths globally. The United States of America is the most affected country with the highest patients of about 0.7 million. Despite great efforts, there is no treatment of this disease. However, prevention and management are the best options. This article describes SARS-CoV-2, disease, prevention and management, treatment and social impact on society. It was analyzed that a combination of antiviral drugs with hydroxyl-chloroquine and azithromycin (with the consultation of a medical practitioner) may be the best option to treat the patients, depending on the patient's conditions and symptoms. However, Unani therapy may be useful along with allopathic treatment. It is urgently advised and requested that all the persons should follow the preventive measures, managements and quarantine strictly without any religious discrepancy otherwise the situation may be the worst. Also, there is an urgent requirement to educate our new generation for science and technology to fight against any such disaster in future; if any. There is no need to be panic and proper prevention and management are essential to combat this disease. This article may be useful to create awareness among the public, to prevent, manage and treat COVID-19.

Citing Articles

The role of the behavioral immune system in the expression of short and long-term orientation in young Chilean men during the COVID-19 pandemic.

Figueroa O, Polo P, Torrico-Bazoberry D, Fajardo G, Rodriguez-Sickert C, Valenzuela N BMC Public Health. 2025; 25(1):501.

PMID: 39920642 PMC: 11803946. DOI: 10.1186/s12889-025-21755-y.

Structural equation modeling analysis of health belief model-based determinants of COVID-19 preventive behavior of academic staff: a cross-sectional study.

Zewdie A, Nigusie A, Wolde M BMC Infect Dis. 2024; 24(1):788.

PMID: 39107716 PMC: 11301987. DOI: 10.1186/s12879-024-09697-z.

COVIDHealth: A novel labeled dataset and machine learning-based web application for classifying COVID-19 discourses on Twitter.

Bishal M, Chowdory M, Das A, Kabir M Heliyon. 2024; 10(14):e34103.

PMID: 39100452 PMC: 11295851. DOI: 10.1016/j.heliyon.2024.e34103.

A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions.

Song X, Song W, Cui L, Duong T, Pandy R, Liu H Diagnostics (Basel). 2024; 14(11).

PMID: 38893693 PMC: 11171614. DOI: 10.3390/diagnostics14111168.

Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study.

Ccami-Bernal F, Rojas-Miliano C, Soriano-Moreno D, Fernandez-Guzman D, Quispe-Vicuna C, Hernandez-Bustamante E Rev Peru Med Exp Salud Publica. 2024; 41(1):37-45.

PMID: 38808842 PMC: 11149759. DOI: 10.17843/rpmesp.2024.411.13265.

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Bayan L, Koulivand P, Gorji A . Garlic: a review of potential therapeutic effects. Avicenna J Phytomed. 2014; 4(1):1-14. PMC: 4103721. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Lu H . Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020; 14(1):69-71. DOI: 10.5582/bst.2020.01020. View

Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D . Antiviral effects of Glycyrrhiza species. Phytother Res. 2007; 22(2):141-8. PMC: 7167979. DOI: 10.1002/ptr.2295. View

Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59(3):252-6. PMC: 1746980. DOI: 10.1136/thorax.2003.012658. View

Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View

Li G, De Clercq E . Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020; 19(3):149-150. DOI: 10.1038/d41573-020-00016-0. View

10.

Jiang Z, Liu W, Zhang X, Luo J, Ma Y, Chen J . Anti-HBV active constituents from Piper longum. Bioorg Med Chem Lett. 2013; 23(7):2123-7. DOI: 10.1016/j.bmcl.2013.01.118. View

11.

Wang L, Yang R, Yuan B, Liu Y, Liu C . The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B. 2015; 5(4):310-5. PMC: 4629407. DOI: 10.1016/j.apsb.2015.05.005. View

12.

KONOWALCHUK J, Speirs J . Antiviral effect of commercial juices and beverages. Appl Environ Microbiol. 1978; 35(6):1219-20. PMC: 243010. DOI: 10.1128/aem.35.6.1219-1220.1978. View

13.

Jaimes J, Millet J, Stout A, Andre N, Whittaker G . A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses. Viruses. 2020; 12(1). PMC: 7019228. DOI: 10.3390/v12010083. View

14.

Chang J, Wang K, Yeh C, Shieh D, Chiang L . Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. 2012; 145(1):146-51. DOI: 10.1016/j.jep.2012.10.043. View

15.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

16.

Lin L, Hsu W, Lin C . Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014; 4(1):24-35. PMC: 4032839. DOI: 10.4103/2225-4110.124335. View

17.

Li S, Chen C, Zhang H, Guo H, Wang H, Wang L . Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005; 67(1):18-23. PMC: 7114104. DOI: 10.1016/j.antiviral.2005.02.007. View

18.

Belouzard S, Chu V, Whittaker G . Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A. 2009; 106(14):5871-6. PMC: 2660061. DOI: 10.1073/pnas.0809524106. View

19.

Ren L, Wang Y, Wu Z, Xiang Z, Guo L, Xu T . Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020; 133(9):1015-1024. PMC: 7147275. DOI: 10.1097/CM9.0000000000000722. View

20.

Sexton N, Smith E, Blanc H, Vignuzzi M, Peersen O, Denison M . Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens. J Virol. 2016; 90(16):7415-7428. PMC: 4984655. DOI: 10.1128/JVI.00080-16. View